Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at UBS
Get Alerts SNDX Hot Sheet
Price: $20.16 +0.35%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
UBS analyst David Dai lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ooma (OOMA) PT Raised to $24 at Freedom Broker
- National Bank of Canada (NA:CN) (NTIOF) PT Lowered to Cdn$230 at Desjardins
- VTEX (VTEX) PT Lowered to $5.10 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share